OVERVIEW
|
|
.
|
Carlsson SV, Lilja H.
Perspective on Prostate Cancer
Screening.
Clin Chem. 2019 Jan;65(1):24-27. doi:
10.1373/clinchem.2018.293514. Epub 2018 Nov 20.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Carroll
PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP,
Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington
T, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance
W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C,
Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R,
Shead DA, Freedman-Cass D.
Prostate
Cancer Early Detection, Version 2.2015.
J
Natl Compr Canc Netw. 2015 Dec;13(12):1534-61.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Grubb RL 3rd.
Prostate Cancer:
Update on Early Detection and New Biomarkers.
Mo
Med. 2018 Mar-Apr;115(2):132-134.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Klotz
L.
Laurence
Klotz on the Controversy Surrounding Screening for Prostate
Cancer.
Oncology
(Williston Park). 2016 Aug 15;30(8). pii: 218393.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Lynch
HT, Kosoko-Lasaki O, Leslie SW, Rendell M, Shaw T, Snyder C,
D'Amico AV, Buxbaum S, Isaacs WB, Loeb S, Moul JW, Powell
I.
Screening
for Familial and Hereditary Prostate Cancer.
Int
J Cancer. 2015 Dec 5. doi: 10.1002/ijc.29949. [Epub ahead of
print]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Masterson
TA, Cary C, Cheng L.
Early
detection of prostate cancer: can we have our cake and eat it
too?
Expert
Rev Anticancer Ther. 2016 Jan 13. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Shen
X, Kumar P.
Trade-Off
Between Treatment of Early Prostate Cancer and Incidence of
Advanced Prostate Cancer in the Prostate Screening Era.
J
Urol. 2015 Dec 2. pii: S0022-5347(15)05348-3. doi:
10.1016/j.juro.2015.11.056. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Thompson IM Jr.
The
pendulum swings back: Screening for prostate cancer in 2018.
Cancer. 2018 Jul
1;124(13):2690-2692. doi: 10.1002/cncr.31555. Epub 2018 May 22.
Comment
on: Negoita S et al, Annual Report to the Nation on the Status of
Cancer, part II: Recent changes in prostate cancer trends and
disease characteristics. [Cancer. 2018 Jul 1]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Tikkinen KAO, Dahm P, Lytvyn L, Heen AF, Vernooij RWM, Siemieniuk
RAC, Wheeler R, Vaughan B, Fobuzi AC, Blanker MH, Junod N, Sommer
J, Stirnemann J, Yoshimura M, Auer R, MacDonald H, Guyatt G,
Vandvik PO, Agoritsas T.
Prostate cancer screening with
prostate-specific antigen (PSA) test: a clinical practice
guideline.
BMJ. 2018 Sep 5;362:k3581. doi:
10.1136/bmj.k3581.
Source
| Full
text |
Similar
articles
|
|
|
EFFICACY
|
|
.
|
Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A,
Agoritsas T, Dahm P.
Prostate cancer screening with
prostate-specific antigen (PSA) test: a systematic review and
meta-analysis.
BMJ. 2018 Sep 5;362:k3519. doi:
10.1136/bmj.k3519.
Source
| Full
text |
Similar
articles
|
|
|
GUIDELINES
|
|
.
|
US Preventive Services Task
Force, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K,
Caughey AB, Davidson KW, Doubeni CA, Ebell M, Epling JW Jr, Kemper
AR, Krist AH, Kubik M, Landefeld CS, Mangione CM, Silverstein M,
Simon MA, Siu AL, Tseng CW.
Screening for Prostate
Cancer: US Preventive Services Task Force Recommendation
Statement.
JAMA. 2018 May 8;319(18):1901-1913. doi:
10.1001/jama.2018.3710. Erratum in: JAMA.
2018 Jun 19;319(23):2443.
Source
| Full
text |
Similar
articles | Correction
|
|
|
REDUCING
UNNECESSARY BIOPSY
|
|
.
|
Strope
SA, Andriole GL.
Improving
prostate-specific antigen screening.
J
Clin Oncol. 2010 May 20;28(15):2491-2. doi:
10.1200/JCO.2009.26.9779. Epub 2010 Apr 26
Editorial
relating to:
Vickers
A et
al, Reducing
unnecessary biopsy during prostate cancer screening using a
four-kallikrein panel: an independent replication.
J Clin
Oncol. 2010 May 20;28(15):2493-8. doi: 10.1200/JCO.2009.24.1968.
Epub 2010 Apr 26.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Vickers
A, Cronin A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino
PT, Schröder F, Lilja H.
Reducing
unnecessary biopsy during prostate cancer screening using a
four-kallikrein panel: an independent replication.
J
Clin Oncol. 2010 May 20;28(15):2493-8. doi:
10.1200/JCO.2009.24.1968. Epub 2010 Apr 26.
Source
| Full
text |
Similar
articles
|
|
|
DIGITAL
RECTAL EXAMINATION
|
|
.
|
Naji L, Randhawa H, Sohani Z, Dennis B, Lautenbach D, Kavanagh O,
Bawor M, Banfield L, Profetto J.
Digital Rectal
Examination for Prostate Cancer Screening in Primary Care: A
Systematic Review and Meta-Analysis.
Ann Fam Med. 2018
Mar;16(2):149-154. doi: 10.1370/afm.2205.
Source
| Full
text |
Similar
articles
|
|
|
IMPACT
OF NSAIDs AND STATINS ON PSA LEVELS
|
|
.
|
Chang
SL, Harshman LC, Presti JC Jr.
Impact
of common medications on serum total prostate-specific antigen
levels: analysis of the National Health and Nutrition Examination
Survey.
J
Clin Oncol. 2010 Sep 1;28(25):3951-7. doi:
10.1200/JCO.2009.27.9406. Epub 2010 Aug 2.
Source
| Full
text |
Similar
articles
|
|
|
MRI
FOR PROSTATE CANCER SCREENING
|
|
.
|
Jones
TA, Marks LS.
Re:
A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging
for Prostate Cancer Screening in the General Population.
Eur
Urol. 2017 Feb 20. pii: S0302-2838(17)30101-X. doi:
10.1016/j.eururo.2017.02.012. [Epub ahead of print]
Comment
on: Nam RK, Wallis CJ, et al, A Pilot Study to Evaluate the Role
of Magnetic Resonance Imaging for Prostate Cancer Screening in the
General Population.[ J Urol. 2016 Aug]
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Nam
RK, Wallis CJ, Stojcic-Bendavid J, Milot L, Sherman C, Sugar L,
Haider MA.
A
Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for
Prostate Cancer Screening in the General Population.
J
Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub
2016 Feb 13.
Source
|
Full
text |
Similar
articles
|
|
|
OPTIMAL
TIME TO DISCONTINUE SCREENING
|
|
.
|
Drazer
MW, Huo D, Schonberg MA, Razmaria A, Eggener SE.
Population-based
patterns and predictors of prostate-specific antigen screening
among older men in the United States.
J
Clin Oncol. 2011 May 1;29(13):1736-43. doi:
10.1200/JCO.2010.31.9004. Epub 2011 Mar 28.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Vickers A.
Words of wisdom: Re: Population-based patterns
and predictors of prostate-specific antigen screening among older
men in the United States.
Eur Urol. 2011 Aug;60(2):392.
doi: 10.1016/j.eururo.2011.05.021.
Source
| Full
text |
Similar
articles
|
|
|
SCREENING
AND METASTASIS
|
|
.
|
Fontenot
PA Jr, Nehra A, Parker W, Wyre H, Mirza M, Duchene DA,
Holzbeierlein J, Thrasher JB, Van Veldhuizen P, Lee EK.
Metastatic
prostate cancer in the modern era of PSA screening.
Int
Braz J Urol. 2017 Mar 24;43. doi:
10.1590/S1677-5538.IBJU.2016.0340. [Epub ahead of print]
Source
|
Full
text |
Similar
articles
|
|
|
CLINICAL
TRIALS
|
|
.
|
Osses DF, Remmers S, Schröder FH, van der Kwast T, Roobol MJ.
Results of Prostate Cancer Screening in a Unique Cohort
at 19yr of Follow-up.
Eur Urol. 2018 Nov 9. pii:
S0302-2838(18)30851-0. doi: 10.1016/j.eururo.2018.10.053. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Schröder
FH, Hugosson J, Carlsson S, Tammela T, Määttänen L,
Auvinen A, Kwiatkowski M, Recker F, Roobol MJ.
Screening
for prostate cancer decreases the risk of developing metastatic
disease: findings from the European Randomized Study of Screening
for Prostate Cancer (ERSPC).
Eur
Urol. 2012 Nov;62(5):745-52. doi: 10.1016/j.eururo.2012.05.068.
Epub 2012 Jun 7.
Source
|
Full
text |
Similar
articles
|
|
|
SCREENING
AND PCa SPECIFIC MORTALITY
|
|
|
|
CLINICAL
TRIALS
|
|
.
|
Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church
TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL,
Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB,
Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan
JK, Berg CD; PLCO Project Team.
Mortality results from a
randomized prostate-cancer screening trial.
N Engl J
Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub
2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.
Source
| Full
text |
Similar
articles | Erratum
|
|
|
.
|
Gulati
R, Albertsen PC.
Insights
from the PLCO trial about prostate cancer screening.
Cancer.
2017 Feb 15;123(4):546-548. doi: 10.1002/cncr.30472. Epub 2016 Dec
1.
Source
|
Full
text |
Similar
articles
Editorial
referring to: Pinsky
PF et al., Extended mortality results for prostate cancer
screening in the PLCO trial with median follow-up of 15 years.
Cancer. 2017 Feb 15;123(4):592-599. doi: 10.1002/cncr.30474.
Epub 2016 Dec 1.
Source
/
Full
text
|
|
|
.
|
Osses DF, Remmers S, Schröder FH, van der Kwast T, Roobol MJ.
Results of Prostate Cancer Screening in a Unique Cohort
at 19yr of Follow-up.
Eur Urol. 2018 Nov 9. pii:
S0302-2838(18)30851-0. doi: 10.1016/j.eururo.2018.10.053. [Epub
ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Pinsky PF, Miller E, Prorok P, Grubb R, Crawford ED, Andriole G.
Extended follow-up for prostate cancer incidence and
mortality in the PLCO randomized cancer screening trial.
BJU
Int. 2018 Oct 5. doi: 10.1111/bju.14580. [Epub ahead of print]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Pinsky
PF, Prorok PC, Yu K, Kramer BS, Black A, Gohagan JK, Crawford ED,
Grubb RL, Andriole GL.
Extended
mortality results for prostate cancer screening in the PLCO trial
with median follow-up of 15 years.
Cancer.
2017 Feb 15;123(4):592-599. doi: 10.1002/cncr.30474. Epub
2016 Dec 1.
Source
|
Full
text |
Similar
articles
|
|
|
.
|
Schröder
FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V,
Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis
LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A,
Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber
A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen
A; ERSPC Investigators.
Screening
and prostate cancer mortality: results of the European Randomised
Study of Screening for Prostate Cancer (ERSPC) at 13 years of
follow-up.
Lancet.
2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0.
Epub 2014 Aug 6.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S,
Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ,
Recker F, Berenguer A, Määttänen L, Bangma CH, Aus
G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss
SM, de Koning HJ, Auvinen A; ERSPC Investigators.
Screening
and prostate-cancer mortality in a randomized European study.
N
Engl J Med. 2009 Mar 26;360(13):1320-8. doi:
10.1056/NEJMoa0810084. Epub 2009 Mar 18.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S,
de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL,
Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján
M, Villers A, Feuer EJ, de Koning HJ, Mariotto AB, Etzioni R.
Reconciling the Effects of Screening on Prostate Cancer
Mortality in the ERSPC and PLCO Trials.
Ann Intern Med.
2017 Oct 3;167(7):449-455. doi: 10.7326/M16-2586. Epub 2017 Sep 5.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Vickers AJ.
Prostate Cancer Screening: Time to
Question How to Optimize the Ratio of Benefits and Harms.
Ann
Intern Med. 2017 Oct 3;167(7):509-510. doi: 10.7326/M17-2012. Epub
2017 Sep 5.
Comment
on: Tsodikov A et al, Reconciling the Effects of Screening on
Prostate Cancer Mortality in the ERSPC and PLCO Trials. [Ann
Intern Med. 2017]
Source
| Full
text |
Similar
articles
|
|
|
.
|
Xia J,
Gulati R, Au M, Gore JL, Lin DW, Etzioni R.
Effects
of screening on radical prostatectomy efficacy: the prostate
cancer intervention versus observation trial.
J
Natl Cancer Inst. 2013 Apr 17;105(8):546-50. doi:
10.1093/jnci/djt017. Epub 2013 Feb 14.
Source
| Full
text |
Similar
articles
|
|
|
.
|
Zolot J.
Study Finds Overall Prostate Cancer Mortality
Decreases with PSA Screening.
Am
J Nurs. 2017 Dec;117(12):16. doi:
10.1097/01.NAJ.0000527472.38965.1f.
Comment
on: Tsodikov A et al, Reconciling the Effects of Screening on
Prostate Cancer Mortality in the ERSPC and PLCO Trials. [Ann
Intern Med. 2017]
Source
|
Fulltext
|
Similar
articles
|
|
|
SINGLE
PSA SCREENING INTERVENTION
|
|
.
|
Barry MJ.
Screening for Prostate Cancer: Is the Third
Trial the Charm?
JAMA. 2018 Mar 6;319(9):868-869. doi:
10.1001/jama.2018.0153. Erratum in: JAMA.
2018 Apr 10;319(14 ):1510
Comment
on: Martin RM et al., Effect
of a Low-Intensity PSA-Based Screening Intervention on Prostate
Cancer Mortality: The CAP Randomized Clinical Trial. (JAMA. 2018
Mar 6)
Source
| Full
text |
Similar
articles | Erratum
|
|
|
.
|
Kelsey R.
Prostate
cancer: Solo PSA test does not lower mortality.
Nat
Rev Urol. 2018 Mar 27. doi: 10.1038/nrurol.2018.41. [Epub ahead of
print]
Comment on:
Martin RM et al., Effect
of a Low-Intensity PSA-Based Screening Intervention on Prostate
Cancer Mortality: The CAP Randomized Clinical Trial. (JAMA. 2018
Mar 6)
Source
| Full
text |
Similar
articles
|
|
|
.
|
Martin RM, Donovan JL, Turner EL, Metcalfe C, Young GJ, Walsh EI,
Lane JA, Noble S, Oliver SE, Evans S, Sterne JAC, Holding P,
Ben-Shlomo Y, Brindle P, Williams NJ, Hill EM, Ng SY, Toole J,
Tazewell MK, Hughes LJ, Davies CF, Thorn JC, Down E, Davey Smith
G, Neal DE, Hamdy FC; CAP Trial Group.
Effect of a
Low-Intensity PSA-Based Screening Intervention on Prostate Cancer
Mortality: The CAP Randomized Clinical Trial.
JAMA. 2018
Mar 6;319(9):883-895. doi: 10.1001/jama.2018.0154.
Source
| Full
text |
Similar
articles
|
|
|
BOOKS
|
|
.
|
Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.
Prostate-Specific Antigen-Based Screening for Prostate
Cancer: A Systematic Evidence Review for the U.S. Preventive
Services Task Force [Internet].
PubMed Health, Rockville
(MD): Agency for Healthcare Research and Quality (US); 2018 May.
Source
| Book
|
Similar
articles
|
|
|
.
|
Kramer
BS et al, PDQ Screening and Prevention Editorial Board.
Prostate
Cancer Screening (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2017 Feb 15.
Source
|
Sections
|
Full
text |
Similar
articles
|
|
|
.
|
Kramer
BS et al, PDQ Screening and Prevention Editorial Board.
Prostate
Cancer Screening (PDQ®): Patient Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2017 Feb 17.
Source
|
Sections
|
Full
text |
Similar
articles
|
|
|
|
Miller Croswell
J et al., PDQ Screening and
Prevention Editorial Board.
Prostate Cancer
Screening (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Dec 13.
Source
/
Similar
articles .
|
|
|
|
Miller Croswell
J et al., PDQ Screening and
Prevention Editorial Board.
Prostate Cancer
Screening (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Oct 18.
Source
.
Similar
articles
|
|
|
.
|
Miller Croswell
J et al., PDQ Screening and
Prevention Editorial Board.
Prostate Cancer
Screening (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Aug 2.
Source
| Book
|
Similar
articles
|
|
|
.
|
Miller Croswell
J et al., PDQ Screening and
Prevention Editorial Board.
Prostate Cancer
Screening (PDQ®): Health Professional Version.
PDQ
Cancer Information Summaries [Internet]. Bethesda (MD): National
Cancer Institute (US); 2019 Mar 22.
Source
| Book
|
Similar
articles
|
|
|
|
|
|
|